4//SEC Filing
Vargeese Chandra 4
Accession 0000899243-23-005565
CIK 0001631574other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 8:15 PM ET
Size
8.5 KB
Accession
0000899243-23-005565
Insider Transaction Report
Form 4
Vargeese Chandra
See Remarks
Transactions
- Sale
Ordinary Shares
2023-02-16$4.03/sh−10,249$41,303→ 106,624 total - Award
Share Option (right to buy)
2023-02-17+295,400→ 295,400 totalExercise: $4.75Exp: 2033-02-17→ Ordinary Shares (295,400 underlying)
Footnotes (4)
- [F1]On February 16, 2023, the reporting person sold 10,249 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 15, 2023. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $4.03 to $4.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Includes 1,500 ordinary shares acquired on July 14, 2022, and 4,278 ordinary shares acquired on January 14, 2023, under the issuer's 2019 Employee Share Purchase Plan.
- [F4]The option vests as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657675
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 8:15 PM ET
- Size
- 8.5 KB